Pfizer (PFE), Valneva Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15

Go back to Pfizer (PFE), Valneva Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
Pfizer Inc. (NYSE: PFE) Delayed: 27.66 +0.02 (0.07%)
Previous Close $27.64    52 Week High $37.39 
Open $27.64    52 Week Low $28.25 
Day High $27.66    P/E 16.76 
Day Low $27.34    EPS $1.65 
Volume 75,587,710